Ruffer LLP’s Halozyme HALO Stock Holding History

Ruffer LLP’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,121	Closed	-$1.76M	–	206
2025 Q4	$1.76M	Sell	26,121 -4,078	-14%	-$274K	0.08%	125
2025 Q3	$2.21M	Sell	30,199 -13,229	-30%	-$879K	0.12%	84
2025 Q2	$2.26M	Sell	43,428 -6,986	-14%	-$398K	0.1%	84
2025 Q1	$3.22M	Buy	+50,414	New	+$2.93M	0.12%	75

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ruffer LLP's HALO Position: Q1 2026 in Review

Ruffer LLP sold out of Halozyme (HALO) in Q1 2026, closing a stake of 26,121 shares — an estimated $1.76M sold.

Ruffer LLP first reported a position in HALO in Q1 2025 and held it in 4 quarters. The position peaked at $3.22M in Q1 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Ruffer LLP reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
Ruffer LLP sold 26,121 Halozyme shares in Q1 2026, an estimated $1.76M.
Ruffer LLP first reported a position in Halozyme in Q1 2025 and held it in 4 quarters.
Ruffer LLP's Halozyme position peaked at $3.22M in Q1 2025.
636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Ruffer LLP's 13F filing for Q1 2026, filed 13 May 2026.